Topics

Glioblastoma | Diagnosis | Magnetic resonance imaging | Differentiation Necrosis-Pseudoprogression and Necrosis-Tumor

Home > Publications > Topics > Glioblastoma > Diagnosis > Magnetic resonance imaging > Differentiation Necrosis-Pseudoprogression

Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis

Khalaj K, Jacobs MA, Zhu JJ, Esquenazi Y, Hsu S, Tandon N, Akhbardeh A, Zhang X, Riascos R, Kamali A.
The Use of Apparent Diffusion Coefficient Values for Differentiating Bevacizumab-Related Cytotoxicity from Tumor Recurrence and Radiation Necrosis in Glioblastoma.
Cancers (Basel). 2024 Jul 2;16(13):2440. doi: 10.3390/cancers16132440. PMID: 39001500. Observational study. ˍ

Differentiating radiation necrosis from tumor recurrence

Lv XQ, Shen WR, Guo Z, Xie XD.
Diagnostic value and efficacy of multimodal magnetic resonance imaging in differentiating radiation necrosis from tumor recurrence in glioblastomas.
Acta Radiol. 2025 Feb 4:2841851241310392. doi: 10.1177/02841851241310392. PMID: 39905844. Observational study˰ ˍ